CGA and plasma cell myeloma: The CgA-dependent regulation of the angiogenic switch has been demonstrated in the bone marrow of patients with multiple myeloma and experimental murine models of the disease further strengthening the contention that the balance between pro- and anti-angiogenic CgA-derived peptides has important physiopathological consequences [17].